Search

Xiaoming Liu

Examiner (ID: 709, Phone: (571)270-0384 , Office: P/2812 )

Most Active Art Unit
2812
Art Unit(s)
2812
Total Applications
629
Issued Applications
504
Pending Applications
79
Abandoned Applications
79

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7587390 [patent_doc_number] => 20110281900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'Crystalline Pharmaceutical' [patent_app_type] => utility [patent_app_number] => 13/107780 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 12115 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281900.pdf [firstpage_image] =>[orig_patent_app_number] => 13107780 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/107780
Crystalline pharmaceutical May 12, 2011 Issued
Array ( [id] => 9749479 [patent_doc_number] => 08840950 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore' [patent_app_type] => utility [patent_app_number] => 13/105383 [patent_app_country] => US [patent_app_date] => 2011-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 5314 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13105383 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/105383
Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore May 10, 2011 Issued
Array ( [id] => 5936042 [patent_doc_number] => 20110212139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'HIGH-DENSITY LIPOPROTEIN COATED MEDICAL DEVICES' [patent_app_type] => utility [patent_app_number] => 13/102791 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7803 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212139.pdf [firstpage_image] =>[orig_patent_app_number] => 13102791 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/102791
High-density lipoprotein coated medical devices May 5, 2011 Issued
Array ( [id] => 7573024 [patent_doc_number] => 20110268680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'HEAT STABLE PROTEIN INGREDIENTS' [patent_app_type] => utility [patent_app_number] => 13/098694 [patent_app_country] => US [patent_app_date] => 2011-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 64 [patent_no_of_words] => 14127 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20110268680.pdf [firstpage_image] =>[orig_patent_app_number] => 13098694 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/098694
Heat stable protein ingredients May 1, 2011 Issued
Array ( [id] => 6090358 [patent_doc_number] => 20110218148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/079400 [patent_app_country] => US [patent_app_date] => 2011-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11547 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218148.pdf [firstpage_image] =>[orig_patent_app_number] => 13079400 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/079400
PHARMACEUTICAL COMPOSITION Apr 3, 2011 Abandoned
Array ( [id] => 8128621 [patent_doc_number] => 20120088848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'METHODS AND COMPOSITIONS FOR CONTROLLED POLYPEPTIDE SYNTHESIS' [patent_app_type] => utility [patent_app_number] => 13/076953 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 36789 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088848.pdf [firstpage_image] =>[orig_patent_app_number] => 13076953 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/076953
METHODS AND COMPOSITIONS FOR CONTROLLED POLYPEPTIDE SYNTHESIS Mar 30, 2011 Abandoned
Array ( [id] => 7697084 [patent_doc_number] => 20110229506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'METHOD FOR CANCER IMMUNOTHERAPY' [patent_app_type] => utility [patent_app_number] => 13/053996 [patent_app_country] => US [patent_app_date] => 2011-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13571 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229506.pdf [firstpage_image] =>[orig_patent_app_number] => 13053996 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/053996
Method for cancer immunotherapy Mar 21, 2011 Issued
Array ( [id] => 6102827 [patent_doc_number] => 20110166320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'SOMATOSTATIN ANALOGUES' [patent_app_type] => utility [patent_app_number] => 13/048935 [patent_app_country] => US [patent_app_date] => 2011-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8545 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166320.pdf [firstpage_image] =>[orig_patent_app_number] => 13048935 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/048935
Somatostatin analogues Mar 15, 2011 Issued
Array ( [id] => 6189800 [patent_doc_number] => 20110172157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'SOMATOSTATIN ANALOGUES' [patent_app_type] => utility [patent_app_number] => 13/048932 [patent_app_country] => US [patent_app_date] => 2011-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8547 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172157.pdf [firstpage_image] =>[orig_patent_app_number] => 13048932 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/048932
Somatostatin analogues Mar 15, 2011 Issued
Array ( [id] => 10110068 [patent_doc_number] => 09145472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-29 [patent_title] => 'Charge reversible polymers' [patent_app_type] => utility [patent_app_number] => 13/033247 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 6806 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13033247 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/033247
Charge reversible polymers Feb 22, 2011 Issued
Array ( [id] => 7663609 [patent_doc_number] => 20110312878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'PHARMACOLOGICALLY ACTIVE PEPTIDE CONJUGATES HAVING A REDUCED TENDENCY TOWARDS ENZYMATIC HYDROLYSIS' [patent_app_type] => utility [patent_app_number] => 13/027475 [patent_app_country] => US [patent_app_date] => 2011-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31051 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312878.pdf [firstpage_image] =>[orig_patent_app_number] => 13027475 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/027475
PHARMACOLOGICALLY ACTIVE PEPTIDE CONJUGATES HAVING A REDUCED TENDENCY TOWARDS ENZYMATIC HYDROLYSIS Feb 14, 2011 Abandoned
Array ( [id] => 9427835 [patent_doc_number] => 08703912 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Processes for removal of dibenzofulvene' [patent_app_type] => utility [patent_app_number] => 13/020838 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14065 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13020838 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/020838
Processes for removal of dibenzofulvene Feb 3, 2011 Issued
Array ( [id] => 6002807 [patent_doc_number] => 20110118179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'CATION COMPLEXES OF INSULIN COMPOUND CONJUGATES, FORMULATIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/012146 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 57251 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118179.pdf [firstpage_image] =>[orig_patent_app_number] => 13012146 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/012146
Cation complexes of insulin compound conjugates, formulations and uses thereof Jan 23, 2011 Issued
Array ( [id] => 6186190 [patent_doc_number] => 20110124553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'INSULIN-OLIGOMER CONJUGATES, FORMULATIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/008094 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 57027 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124553.pdf [firstpage_image] =>[orig_patent_app_number] => 13008094 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/008094
Insulin-oligomer conjugates, formulations and uses thereof Jan 17, 2011 Issued
Array ( [id] => 6187755 [patent_doc_number] => 20110171196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'METHODS OF TREATMENT AND USES FOR CAMKII AND ITS INTERACTION WITH HDACS AND CALPAIN' [patent_app_type] => utility [patent_app_number] => 12/984421 [patent_app_country] => US [patent_app_date] => 2011-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21155 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171196.pdf [firstpage_image] =>[orig_patent_app_number] => 12984421 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/984421
METHODS OF TREATMENT AND USES FOR CAMKII AND ITS INTERACTION WITH HDACS AND CALPAIN Jan 3, 2011 Abandoned
Array ( [id] => 5968970 [patent_doc_number] => 20110150837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Amphiphilic polymer functionalized by methionine' [patent_app_type] => utility [patent_app_number] => 12/977816 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6030 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150837.pdf [firstpage_image] =>[orig_patent_app_number] => 12977816 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/977816
Amphiphilic polymer functionalized by methionine Dec 22, 2010 Abandoned
Array ( [id] => 6000611 [patent_doc_number] => 20110117057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS' [patent_app_type] => utility [patent_app_number] => 12/973020 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37463 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117057.pdf [firstpage_image] =>[orig_patent_app_number] => 12973020 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/973020
NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS Dec 19, 2010 Abandoned
Array ( [id] => 5972495 [patent_doc_number] => 20110152188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS OF IGF/I PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/969619 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7918 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152188.pdf [firstpage_image] =>[orig_patent_app_number] => 12969619 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/969619
PHARMACEUTICAL COMPOSITIONS OF IGF/I PROTEINS Dec 15, 2010 Abandoned
Array ( [id] => 6083598 [patent_doc_number] => 20110144014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'CYTOKINE RECEPTOR MODULATORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/968363 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 44922 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144014.pdf [firstpage_image] =>[orig_patent_app_number] => 12968363 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/968363
CYTOKINE RECEPTOR MODULATORS AND USES THEREOF Dec 14, 2010 Abandoned
Array ( [id] => 5944781 [patent_doc_number] => 20110105401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'PEPTIDE COMPOSITION AND A METHOD OF PROMOTING CARTILAGE FORMATION' [patent_app_type] => utility [patent_app_number] => 12/968532 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17175 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105401.pdf [firstpage_image] =>[orig_patent_app_number] => 12968532 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/968532
Peptide composition and a method of promoting cartilage formation Dec 14, 2010 Issued
Menu